ARTICLE | Company News
Theratechnologies other research news
January 15, 1996 8:00 AM UTC
Theratechnologies received a C$350,000 grant from the Research Council of Canada for its work on photodynamic therapy of chronic myeloid leukemia. The company's product, R1Br2 (rhodamine diBromo), a d...